Cargando…
Long‐term safety and efficacy of trifarotene 50 μg/g cream, a first‐in‐class RAR‐γ selective topical retinoid, in patients with moderate facial and truncal acne
BACKGROUND: Treatment for both facial and truncal acne has not sufficiently been studied. OBJECTIVES: To evaluate the long‐term safety and efficacy of trifarotene in both facial and truncal acne. METHODS: In a multicentre, open‐label, 52‐week study, patients with moderate facial and truncal acne rec...
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004112/ https://www.ncbi.nlm.nih.gov/pubmed/31306527 http://dx.doi.org/10.1111/jdv.15794 |